CD177 and glioma: As a subject for future studies, the signaling pathways initiated by gp120-activated cell surface receptors that may lead to the activation of glycolytic pathways in gliomas should be further investigated as a potential strategy to identify putative drug targets for glioma tumors in HIV infected patients.